The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Body fat composition as biomarker for clinical outcomes and treatment tolerance in high-risk prostate cancer.
 
Anurag Saraf
No Relationships to Disclose
 
Zhongyi Zhang
No Relationships to Disclose
 
Jack Qian
No Relationships to Disclose
 
Christian V Gurthier
No Relationships to Disclose
 
Jakob Weiss
Consulting or Advisory Role - Onc.AI
 
Vinayak Muralidhar
Employment - Northwest Permanente
 
Subha Perni
No Relationships to Disclose
 
Danielle Sara Bitterman
No Relationships to Disclose
 
Benjamin Harris Kann
Honoraria - Putnam Associates
 
Anthony Victor D'Amico
No Relationships to Disclose
 
Hugo Aerts
No Relationships to Disclose
 
Raymond H. Mak
Consulting or Advisory Role - AstraZeneca; ViewRay
Research Funding - AstraZeneca (Inst); ViewRay
 
Paul L. Nguyen
Stock and Other Ownership Interests - Augmenix; Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Augmenix; Bayer; Biogen (I); Blue Earth Diagnostics; Boston Scientific; Coda; Dendreon; Ferring; GenomeDx; GigaGen (I); Janssen Oncology; Medivation; Myovant Sciences; Nanobiotix
Research Funding - Astellas Pharma; Bayer; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring